Introgen (INGN) Disqualified in Nasdaq Global Market for Non Compliance, Cedes Listing to Nasdaq Capital Market, Article Posted on BeaconEquity.com
Effective November 19, Introgen's common stock will be transferred from the Nasdaq Global Market to the Nasdaq Capital: the company’s shares will continue to be listed provided that Introgen can demonstrate compliance with all listing requirements.
(EMAILWIRE.COM, November 20, 2008 ) DALLAS, Texas - BeaconEquity.com announces the publication of “Introgen (INGN) Disqualified in Nasdaq Global Market for Non Compliance, Cedes Listing to Nasdaq Capital Market.”
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m - Click on News and Commentary
In the article the author writes:
"After being notified that it was not in compliance with certain of the continued listing requirements for the Nasdaq Global Market, Introgen announced it has received notice of listing transfer from the Nasdaq Hearings Panel. … The biopharmaceutical company previously announced it received a letter from Nasdaq indicating that it was not in compliance with Marketplace Rule 4450(b)(1)(A), requiring a minimum $50 million market value of listed securities for continued inclusion on the Nasdaq Global Market.”
Introgen announces financial results for the quarter while highlighting recent corporate developments:
“Revenue was $331,000 for the quarter ended September 30, 2008, compared to revenue of $139,000 for the quarter ended September 30, 2007. Introgen reported net loss of $6 million, or 14 cents per share, for the quarter ended September 30, 2008. … Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting:
http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m - Click on News and Commentary
In the article the author writes:
"After being notified that it was not in compliance with certain of the continued listing requirements for the Nasdaq Global Market, Introgen announced it has received notice of listing transfer from the Nasdaq Hearings Panel. … The biopharmaceutical company previously announced it received a letter from Nasdaq indicating that it was not in compliance with Marketplace Rule 4450(b)(1)(A), requiring a minimum $50 million market value of listed securities for continued inclusion on the Nasdaq Global Market.”
Introgen announces financial results for the quarter while highlighting recent corporate developments:
“Revenue was $331,000 for the quarter ended September 30, 2008, compared to revenue of $139,000 for the quarter ended September 30, 2007. Introgen reported net loss of $6 million, or 14 cents per share, for the quarter ended September 30, 2008. … Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale cGMP manufacturing facility.”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting:
http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Press Release Keywords:
stock market, investing, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, introgen inc.
stock market, investing, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, introgen inc.
|
Stop Being Fooled By "Penny Stock Picks"
Subscribe To The #1 Rated MicroCap Stock Newsletter. MicroCapster.com Top Penny Stock TEMN Key Investment Highlights & Latest News on Gainer TEMN! StockSource.us/temn.html Your text Ads here! Ads are only $575 per month. Ads are placed same day. Contac Us Emailwire.com/contact.php |